% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • dlhild Oct 30, 2012 7:46 PM Flag


    Anyone, please clarify this for me.

    Is the DOD in the process of terminating their BioFoam study?

    Is CRY still trying to obtain U.S. FDA approval for BioFoam, or has CRY more or less given up on obtaining U.S. FDA approval?

    IMO, without U.S. FDA approval, it is difficult for me to see much in the way of revenue/profits coming from this source.

    Please help me sort this out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'm not entirely sure but think they are trying to expand the uses of Biofoam in Europe before they even consider doing anything in USA. I think it is a lot cheaper and more cost effective.

      • 1 Reply to thebuckeye777
      • dlhild Oct 30, 2012 9:10 PM Flag

        IMO it is difficult to make money in Europe in any event. It is an easier market than the U.S. to enter, but difficult to make money there. The markets are fragmented by country, and at least in countries like Spain again fragmented by region within the country. To make good money, CRY needs lots of sales plus good margins. Related to this is that I suspect that part of the reason for poor historic PerClot sales is the fragmented nature of the European market too. The earnings transcript made it sound a little like the good horse BioFoam has been sent to the glue factory. Also, to introduce a new product into a fragmented market adds to the complexity, so it would seem anyway. Buckeye, thank you for your response on this matter. If you get this sorted out better, please post.

12.18-0.07(-0.57%)4:02 PMEDT